RU58841 , 99% , 154992-24-2
CAS NO.:154992-24-2
Empirical Formula: C17H18F3N3O3
Molecular Weight: 369.34
MDL number: MFCD00925776
EINECS: 1592732-453-0
| Pack Size | Price | Stock | Quantity |
| 250mg | RMB192.80 | In Stock |
|
| 1g | RMB468.00 | In Stock |
|
| 5g | RMB1404.00 | In Stock |
|
| 25g | RMB3999.20 | In Stock |
|
| others | Enquire |
PRODUCT Properties
| Boiling point: | 493.6±55.0 °C(Predicted) |
| Density | 1.39 |
| storage temp. | Sealed in dry,Store in freezer, under -20°C |
| solubility | DMF: 33 mg/ml; DMSO: 25 mg/ml; Ethanol: 33 mg/ml; Ethanol:PBS(pH 7.2) (1:5): 0.16 mg/ml |
| form | Powder |
| pka | 15.09±0.10(Predicted) |
| color | White to off-white |
| InChI | InChI=1S/C17H18F3N3O3/c1-16(2)14(25)23(15(26)22(16)7-3-4-8-24)12-6-5-11(10-21)13(9-12)17(18,19)20/h5-6,9,24H,3-4,7-8H2,1-2H3 |
| InChIKey | ARBYGDBJECGMGA-UHFFFAOYSA-N |
| SMILES | C(#N)C1=CC=C(N2C(=O)N(CCCCO)C(C)(C)C2=O)C=C1C(F)(F)F |
Description and Uses
RU-58841 is a non-steroidal antiandrogen that binds to the androgen receptor (Kd = 1.8, 1.1, 5.6, 1.3, and 1.4 nM for human, rat, mouse, hamster prostate, and hamster flank organ receptors, respectively). In vivo, topical administration of RU-58841 (1-100 μg per animal) reduces size of the flank organ without affecting sex organs in a dose-dependent manner in hamsters. It has no effect on sex organ weight in intact rats when administered percutaneously, subcutaneously, or orally at doses up to 1 mg per animal. RU-58841 (5% v/v) also induces hair regrowth in the bald frontal scalps of postpubertal stumptailed macaques, a model for male pattern baldness.
Avoid hair loss: RU58841 is a non-steroidal antiandrogenic medication that was initially developed in the 1980s as a topical treatment remedy for acne and male pattern baldness – androgenetic alopecia.
Safety
| Symbol(GHS) | ![]() GHS05 |
| Signal word | Danger |
| Hazard statements | H314-H290 |
| Precautionary statements | P501-P234-P264-P280-P390-P303+P361+P353-P301+P330+P331-P363-P304+P340+P310-P305+P351+P338+P310-P406-P405 |





